 |
 |
|
Home |
Current Issue |
Past Issues |
In the Clinic |
ACP Journal Club |
CME |
Collections |
Audio/Video |
Mobile |
Subscribe |
Tools |
Help |
ACP Online
|
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
15 October 1994 | Volume 121 Issue 8 | Pages 560-567
Objective: To ascertain the prevalence of and risk factors for long-term sequelae from acute Lyme disease.
Design: Population-based, retrospective cohort study.
Setting: A coastal region endemic for Lyme disease.
Participants: Patients with a history of Lyme disease who were previously treated with antibiotics were compared with randomly selected controls.
Measurements: A standardized physical examination, health status measure (Short Form 36), psychometric test battery, and serologic analysis.
Results: Compared with the control group (n = 43), the Lyme group (n = 38; mean duration from disease onset to study evaluation, 6.2 years) had more arthralgias (61% compared with 16%; P < 0.0001); distal paresthesias (16% compared with 2%; P = 0.03); concentration difficulties (16% compared with 2%; P = 0.03); and fatigue (26% compared with 9%; P = 0.04), and they had poorer global health status scores (P = 0.04). The Lyme group also had more abnormal joints (P = 0.02) and more verbal memory deficits (P = 0.01) than did the control group. Overall, 13 patients (34%; 95% CI, 19% to 49%) had long-term sequelae from Lyme disease (arthritis or recurrent arthralgias [n = 6], neurocognitive impairment (n = 4), and neuropathy or myelopathy [n = 3]). Compared with controls, patients who had long-term sequelae had higher IgG antibody titers to the spirochete (P = 0.03) and received treatment later (34.5 months compared with 2.7 months; P < 0.0001).
Conclusions: Persons with a history of Lyme disease have more musculoskeletal impairment and a higher prevalence of verbal memory impairment when compared with those without a history of Lyme disease. Our findings suggest that disseminated Lyme disease may be associated with long-term morbidity.
*Deceased.
Author and Article Information
Requests for Reprints: Nancy A. Shadick, MD, MPH, Department of Rheumatology-Immunology, PB2, Brigham & Women's Hospital, 75 Francis Street, Boston, MA 02115.
ARTICLE
The Long-Term Clinical Outcomes of Lyme Disease: A Population-based Retrospective Cohort Study
Acknowledgments: The authors thank Catherine Lastavica, MD, for her epidemiologic and clinical advice; Richard Shadick, PhD, for his assistance with the neuropsychological training and testing; and Geoffrey Ginsburg, MD, for his clinical advice.
Grant Support: In part by National Institutes for Health grants AR36308, AR20358, and AR07530. Dr. Shadick is supported by an Arthritis Foundation Postdoctoral Fellowship. Dr. Katz is supported by an Arthritis Foundation Investigator Award.
This article has been cited by other articles:
|
|
 |
|
  J. E. Foley, R. N. Brown, M. W. Gabriel, J. Henn, N. Drazenovich, R. Kasten, S. L. Green, and B. B. Chomel Spatial analysis of the exposure of dogs in rural north-coastal California to vectorborne pathogens Vet Rec., November 10, 2007; 161(19): 653 - 657. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. J. Halperin, E. D. Shapiro, E. Logigian, A. L. Belman, L. Dotevall, G. P. Wormser, L. Krupp, G. Gronseth, and C. T. Bever Jr Practice Parameter: Treatment of nervous system Lyme disease (an evidence-based review): Report of the Quality Standards Subcommittee of the American Academy of Neurology Neurology, July 3, 2007; 69(1): 91 - 102. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. Hickie, T. Davenport, D. Wakefield, U. Vollmer-Conna, B. Cameron, S. D Vernon, W. C Reeves, A. Lloyd, and Dubbo Infection Outcomes Study Group Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study BMJ, September 16, 2006; 333(7568): 575. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Glatz, M. Golestani, H. Kerl, and R. R. Mullegger Clinical Relevance of Different IgG and IgM Serum Antibody Responses to Borrelia burgdorferi After Antibiotic Therapy for Erythema Migrans: Long-term Follow-up Study of 113 Patients. Arch Dermatol, July 1, 2006; 142(7): 862 - 868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Cairns Author's response to comments by Sigal and Hassett, Phillips et al., and Shapiro et al. Int. J. Epidemiol., December 1, 2005; 34(6): 1440 - 1443. [Full Text] [PDF]
|
|
|
|
|
|
V. Cairns and J. Godwin Post-Lyme borreliosis syndrome: a meta-analysis of reported symptoms Int. J. Epidemiol., December 1, 2005; 34(6): 1340 - 1345. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. D Shapiro, R. Dattwyler, R. B Nadelman, and G. P Wormser Response to meta-analysis of Lyme borreliosis symptoms Int. J. Epidemiol., December 1, 2005; 34(6): 1437 - 1439. [Full Text] [PDF]
|
|
|
|
|
|
R. F. Kaplan, R. P. Trevino, G. M. Johnson, L. Levy, R. Dornbush, L. T. Hu, J. Evans, A. Weinstein, C. H. Schmid, and M. S. Klempner Cognitive function in post-treatment Lyme disease Do additional antibiotics help? Neurology, June 24, 2003; 60(12): 1916 - 1922. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Shadick, M. H. Liang, C. B. Phillips, K. Fossel, and K. M. Kuntz The Cost-effectiveness of Vaccination Against Lyme Disease Arch Intern Med, February 26, 2001; 161(4): 554 - 561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. G. Seltzer, M. A. Gerber, M. L. Cartter, K. Freudigman, and E. D. Shapiro Long-term Outcomes of Persons With Lyme Disease JAMA, February 2, 2000; 283(5): 609 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. A. Shadick, C. B. Phillips, O. Sangha, E. L. Logigian, R. F. Kaplan, E. A. Wright, A. H. Fossel, K. Fossel, V. Berardi, R. A. Lew, et al. Musculoskeletal and Neurologic Outcomes in Patients with Previously Treated Lyme Disease Ann Intern Med, December 21, 1999; 131(12): 919 - 926. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Primavera, P. Gazzola, A. F. De Maria, J. Treib, M. T. Grauer, R. Woessner, and A. Haass Neuropsychological deficits in neuroborreliosis Neurology, September 1, 1999; 53(4): 895 - 895. [Full Text] [PDF]
|
|
|
|
 |
|
 T. J. Sellati, D. A. Bouis, R. L. Kitchens, R. P. Darveau, J. Pugin, R. J. Ulevitch, S. C. Gangloff, S. M. Goyert, M. V. Norgard, and J. D. Radolf Treponema pallidum and Borrelia burgdorferi Lipoproteins and Synthetic Lipopeptides Activate Monocytic Cells via a CD14-Dependent Pathway Distinct from That Used by Lipopolysaccharide J. Immunol., June 1, 1998; 160(11): 5455 - 5464. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J. Dattwyler, B. J. Luft, M. J. Kunkel, M. F. Finkel, G. P. Wormser, T. J. Rush, E. Grunwaldt, W. A. Agger, M. Franklin, D. Oswald, et al. Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease N. Engl. J. Med., July 31, 1997; 337(5): 289 - 295. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. H. Eckman, A. C. Steere, R. A. Kalish, and S. G. Pauker Cost Effectiveness of Oral as Compared with Intravenous Antibiotic Therapy for Patients with Early Lyme Disease or Lyme Arthritis N. Engl. J. Med., July 31, 1997; 337(5): 357 - 364. [Full Text] [PDF]
|
|
|
|
 |
|
 Long-Term Sequelae of Lyme Borreliosis Persist Despite Antibiotic Treatment Journal Watch Dermatology, December 1, 1994; 1994(1201): 8 - 8. [Full Text]
|
|
|
|
 |
|
 LONG-TERM OUTCOMES OF LYME DISEASE Journal Watch (General), October 28, 1994; 1994(1028): 3 - 3. [Full Text]
|
|
Article
